Related to Biosearch Technologies Acquires Majority Stake in LightSpeed Genomics

• Eric Schadt's Top 5 Genomic Predictions
  Here are the five biggest advances the director of the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai expects to see from genomic research in five years.
  
• 10 Predictions That Will Transform Healthcare
  Peer into GEN's crystal ball for a glimpse of what's to come.
  
• Arrivederci, GINA
  New rules on protecting genetic privacy are under way, as study rekindles debate over sharing vs. protecting data.
  
• Detecting Acquired Drug Resistance in Cancer
  New methods allow noninvasive analysis in blood plasma.
  
• Metagenomics May Hold Key to Novel Antibiotic Discovery
  This relatively new science has the potential to fill a technological void.
  
• A Big Deal’s Winners and Losers
  The benefits, and costs, of Thermo Fisher’s $13.6B Life Tech purchase.
  
• Chips By Choice
  The technology that was slated to make microarrays obsolete has actually helped make them better.
  
• Brain Engineering, CRISPRs, Mindclones, Avatars, and Much More
  GEN’s John Sterling discusses his trip to the Global Future 2045 International Congress.
  
• Parsing the Phenome
  Using metabolic phenotyping approaches, researchers are deconstructing gene-environment interactions and their contributions to disease risk at the personal and population scales.
  
• Six Websites You Need to Bookmark: August Picks
  Check out these websites from GEN's Best of the Web.
  
• CRISPR/Cas Comes of Age—Almost
  Genetic tools based on components of a bacterial adaptive immune system may offer a set of novel tools for adding, deleting, or replacing specific genes in model organisms.
  
• Gene Test Boom Faces Lawsuits
  Testing giant and two rivals clash in court, threatening to cloud a sunny growth forecast.
  
• As Big Deals Resurface, Who’s Next to the Altar?
  Amgen-Onyx, Perrigo-Elan warm an M&A space that had been chilled by an IPO revival.
  
• Takeover Targets: Who Is First on the List?
  Which companies are next in acquisition alley?
  
• Gene Editing Typos
  Researchers use a human cell-based reporter assay to characterize off-target cleavage of CRISPR-associated (Cas)9-based RNA-guided nucleases.
  
• Genome Testing Reduces Overtreatment
  Study after study has shown that molecular diagnostics can help oncologists more effectively treat patients.
  
• Biggest Biotech Trends of 2012
  GEN takes a look back at some key biopharma developments of the past 12 months.
  
• 7 Biotech Trends for the Coming Year
  What does 2013 hold for the industry?
  
• Your Genes, Your Choice?
  Critics say the American College of Medical Genetics and Genomics’ recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy.
  
• Moving Genomics Closer to the Clinic
  Foundation Medicine and Memorial Sloan-Kettering Cancer Center are working to translate genomic information into personalized cancer treatment.